Possible roles ofl-phosphoserine in the pathogenesis of Alzheimer’s disease (original) (raw)

• Adamson P., Hajimohammadreza I., Brammer M. J., Campbell I. C., and Meldrum B. S. (1990) Presynaptic glutamate/quisqualate receptors: Effects on synaptosomal free calcium concentrations.J. Neurochem. 55, 1850–1854.
  Article PubMed CAS Google Scholar
• Andreasen M., Lambert J. D., and Jensen M. S. (1989) Effects of new non-_N_-methyl-d-aspartate antagonists on synaptic transmission in the in vitro rat hippocampus.J. Physiol. 414, 317–336.
  PubMed CAS Google Scholar
• Arai H., Kobayashi K., Ichimiya Y., Kosaka K., and Iizuka R. (1985) Free amino acids in post-mortem cerebral cortices from patients with Alzheimer-type dementia.Neurosci. Res. 2, 486–490.
  Article PubMed CAS Google Scholar
• Balcar V. J. and Johnston G. A. (1972) The structural specificity of the high affinity uptake ofl-glutamate andl-aspartate by rat brain slices.J. Neurochem. 19, 2657–2666.
  Article PubMed CAS Google Scholar
• Bernstein J., Fisher R. S., Zaczek R., and Coyle J. (1985) Dipeptides of glutamate and aspartate may be endogenous neuroexcitants in the rat hippocampal slice.J. Neurosci. 5, 1429–1433.
  PubMed CAS Google Scholar
• Blakely R. D., Robinson M. B., Guarda A. S., and Coyle J. T. (1988) A reexamination of the interaction of_N_-acetyl-l-aspartyl-l-glutamate with a subpopulation of rat brain membrane L-glutamate-sensitive binding sites.Eur. J. Pharmacol. 151, 419–426.
  Article PubMed CAS Google Scholar
• Bradler J. E., Barrionuevo G., Panchalingam K., McKeag D., and Pettegrew J. W. (1991) Actions of phosphomonoesters on CA1 hippocampal neurons as revealed by a combined electrophysiological and nuclear magnetic resonance study.Synapse (in press).
• Bridges R. J., Hearn T. J., Monaghan D. T., and Cotman C. W. (1986) A comparison of 2-amino-4-phosphonubutyric acid (AP4) receptors and [3H]AP4 binding sites in the rat brain.Brain Res. 375, 204–209.
  Article PubMed CAS Google Scholar
• Brown G. G., Levine S. R., Gorell J. M., Pettegrew J. W., Gdowski J. W., Bueri J. A., Helpern J. A., and Welch K. M. A. (1989) In vivo31P NMR profiles of Alzheimer’s disease and multiple subcortical infarct dementia.Neurology 39, 1423–1427.
  PubMed CAS Google Scholar
• Brown T. H., Chapman P. F., Kairiss E. W., and Keenan C. L. (1988) Long-term synaptic potentiation.Science 242, 724–728.
  Article PubMed CAS Google Scholar
• Butcher S. P., Collins J. F., and Roberts P. J. (1983) Characterization of the binding ofDl-[3H]-2-amino-4-phosphonobutyrate tol-glutamate-sensitive sites on rat brain synaptic membranes.Br. J. Pharmacol. 80, 355–364.
  PubMed CAS Google Scholar
• Chalmers D. T., Dewar D., Graham D. I., Brooks D. N., and McCulloch J. (1990) Differential alterations of cortical glutamatergic binding sites in senile dementia of the Alzheimer type.Proc. Natl. Acad. Sci. USA 87, 1352–1356.
  Article PubMed CAS Google Scholar
• Coleman P. A. and Miller R. F. (1989) Kainate receptor-mediated synaptic currents in mudpuppy inner retinal neurons reduced byd-_O_-phosphoserine.J. Neurophys. 62, 495–500.
  CAS Google Scholar
• Cotman C. W., Flatman J. A., Ganong A. H., and Perkins M. N. (1986) Effects of excitatory amino acid antagonists on evoked and spontaneous excitatory potentials in guinea-pig hippocampus.J. Physiol. 378, 403–415.
  PubMed CAS Google Scholar
• Cotman C. W., Geddes J. W., Bridges R. J., and Monaghan D. T. (1989)_N_-methyl-d-aspartate receptors and Alzheimer’s disease.Neurobiol. Aging 10, 603–605.
  Article PubMed CAS Google Scholar
• Cowburn R. F., Hardy J. A., Briggs R. S., and Roberts P. J. (1989) Characterisation, density, and distribution of kainate receptors in normal and Alzheimer’s diseased human brain.J. Neurochem. 52, 140–147.
  Article PubMed CAS Google Scholar
• Davies J. and Watkins J. C. (1982) Actions of D and L forms of 2-amino-5-phosphonovalerate and 2-amino-4-phosphonobutyrate in the cat spinal cord.Brain Res. 235, 378–386.
  Article PubMed CAS Google Scholar
• Ellison D. W., Beal M. F., Mazurek M. F., Bird E. D., and Martin J. B. (1986) A postmortem study of amino acid neurotransmitters in Alzheimer’s disease.Ann. Neurol. 20, 616–621.
  Article PubMed CAS Google Scholar
• Fagg G. E., Foster A. C., Harris E. W., Lanthorn T. H., and Cotman C. W. (1982a) Structure-activity relationships ofl-glutamate receptor ligands: role of the omega-acidic terminal.Neurosci. Lett. 31, 59–64.
  Article PubMed CAS Google Scholar
• Fagg, G. E., Foster A. C., Mena E. E., and Cotman C. W. (1982b) Chloride and calcium ions reveal a pharmacologically distinct population ofl-glutamate binding sites in synaptic membranes: correspondence between biochemical and electrophysiological data.J. Neurosci. 2, 958–965.
  PubMed CAS Google Scholar
• Fletcher E. J., Martin D., Aram J. A., Lodge D., and Honor T. (1988) Quinoxalinediones selectively block quisqualate and kainate receptors and synaptic events in rat neocortex and hippocampus and frog spinal cord in vitro.Br. J. Pharmacol. 95, 585–597.
  PubMed CAS Google Scholar
• Forsythe I. D. and Clements J. D. (1990) Presynaptic glutamate receptors depress excitatory monosynaptic transmission between mouse hippocampal neurones.J. Physiol. 429, 1–16.
  PubMed CAS Google Scholar
• Freund R. K., Crooks S. L., Koerner J. F., and Johnson R. L. (1984) Antagonist activity of phosphorus-containing glutamate analogs in the perforant path.Brain Res. 291, 150–153.
  Article PubMed CAS Google Scholar
• Gannon R. L., Baty L. T., and Terrian D. M. (1989)l(+)-2-amino-4-phosphonobutyrate inhibits the release of both glutamate and dynorphin from guinea pig but not rat hippocampal mossy fiber synaptosomes.Brain Res. 495, 151–155.
  Article PubMed CAS Google Scholar
• Gramsbergen J. B., Mountjoy C. Q., Rossor M. N., Reynolds G. P., Roth M., and Korf J. (1987) A correlative study on hippocampal cation shifts and amino acids and clinico-pathological data in Alzheimer’s disease.Neurobiol. Aging 8, 487–494.
  Article PubMed CAS Google Scholar
• Greenamyre J. T. and Young A. B. (1989) Excitatory amino acids and Alzheimer’s disease.Neurobiol. Aging 10, 593–602.
  Article PubMed CAS Google Scholar
• Henneberry R. C. (1989) The role of neuronal energy in the neurotoxicity of excitatory amino acids.Neurobiol. Aging 10, 611–613.
  Article PubMed CAS Google Scholar
• Hyman B. T., Van Hoesen G. W., and Damasio A. R. (1987) Alzheimer’s disease: Glutamate depletion in the hippocampal perforant pathway zone.Ann. Neurol. 22, 37–40.
  Article PubMed CAS Google Scholar
• Johnson K. M., Snell L. D., Jones S. M., and Qi H. (1988) Glycine antagonist activity of simple glycine analogues and_N_-methyl-d-aspartate antagonists.Neurol. Neurobiol. 46, 551–558.
  CAS Google Scholar
• Kamiya K., Cruse W. B. T., and Kennard O. (1983) The arsonomethyl group as an analogue of phosphate.Biochem. J. 213, 217–223.
  PubMed CAS Google Scholar
• Kessler M., Baudry M., and Lynch G. (1987) Use of cystine to distinguish glutamate binding from glutamate sequestration.Neurosci. Lett. 81, 221–226.
  PubMed CAS Google Scholar
• Klunk W. E., McClure R. J., and Pettegrew J. W. (1991) L-Phosphoserine, a metabolite elevated in Alzheimer’s disease, interacts with specificl-glutamate receptor subtypes.J. Neurochem. 56, 1997–2003.
  Article PubMed CAS Google Scholar
• Koerner J. F., Johnson R. L., Freund R. K., Robinson M. B., and Crooks S. L. (1983) Structure-function relationships for gamma-substituted glutamate analogues on dentate granule cells.Brain Res. 272, 299–309.
  Article PubMed CAS Google Scholar
• Kosik K. S., Orecchio L. D., Bakalis S., and Neve R. L. (1989) Developmentally regulated expression of specific tau sequences.Neuron 2, 1389–1397.
  Article PubMed CAS Google Scholar
• Lanthorn T. H., Ganong A. H., and Cotman C. W. (1984) 2-Amino-4-phosphonobutyrate selectively blocks mossy fiber-CA3 responses in guinea pig but not rat hippocampus.Brain Res. 290, 174–178.
  Article PubMed CAS Google Scholar
• Mann D. M. A. (1985) The neuropathology of Alzheimer’s disease: A review with pathogenetic, aetiological and therapeutic considerations.Mech. Ageing Dev. 31, 213–255.
  Article PubMed CAS Google Scholar
• Maragos. W. F., Greenamyre J. T., Penney J. B., Jr., and Young A. B. (1987) Glutamate dysfunction in Alzheimer’s disease: An hypothesis.Trends Neurosci. 10, 65–68.
  Article CAS Google Scholar
• Mattson M. P., Guthrie P. B., and Kater S. B. (1989) Intrinsic factors in the selective vulnerability of hippocampal pyramidal neurons.Prog. Clin. Biol. Res. 317, 333–351.
  PubMed CAS Google Scholar
• May P. C. (1989) Selectivity of excitotoxic mechanisms in Alzheimer’s disease.Neurobiol. Aging 10, 606–608.
  Article PubMed CAS Google Scholar
• McBain C. J., Kleckner N. W., Wyrick S., and Dingledine R. (1989) Structural requirements for activation of the glycine coagonist site of_N_-methyl-d-aspartate receptors expressed in Xenopus oocytes.Mol. Pharmacol. 36, 556–565.
  PubMed CAS Google Scholar
• McClure, R. J., Klunk W. E., and Pettegrew J. W. (1990) Computer molecular modeling of L-phosphoserine to the NMDA receptor. (Abstract)Biol. Psychiatry 27(9A), 76A-77A.
  Google Scholar
• McClure R. J. and Pettegrew J. W. (1989) Computer molecular modeling ofl-glutamate agonists and antagonists. (Abstract).Neurology 39 (Suppl. 1), 398.
  Google Scholar
• McIlwain H. and Bachelard H. S. (1985)Biochemistry and the Central Nervous System. Churchill Livingstone, New York.
  Google Scholar
• McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. (1984) Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer’s disease.Neurology 34, 939–944.
  PubMed CAS Google Scholar
• Miotto O., Gonzalez R. G., Buonanno F., and Growdon J. (1986) In vitro31P NMR spectroscopy detects altered phospholipid metabolism in Alzheimer’s disease.Can. J. Neurol. Sci. 13, (Suppl.) 535–539.
  Google Scholar
• Monaghan D. T., McMills M. C., Chamberlin A. R., and Cotman C. W. (1983) Synthesis of 2-amino-4-phosphonobutyric acid and characterization of its binding to rat brain membranes: a selective ligand for the chloride/calcium-dependent class ofl-glutamate binding sites.Brain Res. 278, 137–144.
  Article PubMed CAS Google Scholar
• Monahan J. B., Corpus V. M., Hood W. F., Thomas J. W., and Compton R. P. (1989) Characterization of a [3H]glycine recognition site, a modulatory site of the N-methyl-D-aspartate receptor complex.J. Neurochem. 53, 370–375.
  Article PubMed CAS Google Scholar
• Mouradian M. M., Contreras P. C., Monahan J. B., and Chase T. N. (1988) [3H]MK-801 binding in Alzheimer’s disease.Neurosci. Lett. 93, 225–230.
  Article PubMed CAS Google Scholar
• Murphy D. E., Hutchison A. J., Hurt S. D., Williams M., and Sills M. A. (1988) Characterization of the binding of [3H]-CGS 19755: A novel_N_-methyl-d-aspartate antagonist with nanomolar affinity in rat brain.Br. J. Pharmacol. 95, 932–938.
  PubMed CAS Google Scholar
• Murphy D. E., Schneider J., Boehm C., Lehmann J., and Williams M. (1987a) Binding of [3H]3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid to rat brain membranes: a selective, high-affinity ligand for_N_-methyl-d-aspartate receptors.J. Pharmacol. Exp. Ther. 240, 778–784.
  PubMed CAS Google Scholar
• Murphy D. E., Snowhill E. W., and Williams M. (1987b) Characterization of quisqualate recognition sites in rat brain tissue using DL-[3H]alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) and a filtration assay.Neurochem. Res. 9, 775–782.
  Article Google Scholar
• Naito S. and Ueda T. (1983) Adenosine triphosphate-dependent uptake of glutamate into protein I-associated synaptic vesicles.J. Biol. Chem. 258, 696–699.
  PubMed CAS Google Scholar
• Naito S. and Ueda T. (1985) Characterization of glutamate uptake into synaptic vesicles.J. Neurochem. 44, 99–109.
  Article PubMed CAS Google Scholar
• Nicholls D. G. (1989) Release of glutamate, aspartate, and gamma-aminobutyric acid from isolated nerve terminals.J. Neurochem. 52, 331–341.
  Article PubMed CAS Google Scholar
• Nicoletti F., Meek J. L., Iadarola M. J., Chuang D. M., Roth B. L., and Costa E. (1986a) Coupling of inositol phospholipid metabolism with excitatory amino acid recognition sites in rat hippocampus.J. Neurochem. 46, 40–46.
  Article PubMed CAS Google Scholar
• Nicoletti F., Wroblewski J. T., Iadarola M. J., and Costa E. (1986b) Serine-O-phosphate, an endogenous metabolite inhibits the stimulation of inositol phospholipid hydrolysis elicited by ibotenic acid in rat hippocampal slices.Neuropharmacology 25, 335–338.
  Article PubMed CAS Google Scholar
• Ninomiya H., Fukunaga R., Taniguchi T., Fujiwara M., Shimohama S., and Kameyama M. (1990) [3H]_N_-[1-(2-thienyl)cyclohexyl]-3,4-piperidine ([3H]TCP) binding in human frontal cortex: decreases in Alzheimer-type dementia.J. Neurochem. 54, 526–532.
  Article PubMed CAS Google Scholar
• Olney J. W., Ho O. L., and Rhee V. (1971) Cytotoxic effects of acidic and sulphur containing amino acids on the infant mouse central nervous system.Exp. Brain Res. 14, 61–76.
  Article PubMed CAS Google Scholar
• Olney J. W., Price M. T., Samson L., and Labruyere J. (1986) The role of specific ions in glutamate neurotoxicity.Neurosci. Lett. 65, 65–71.
  Article PubMed CAS Google Scholar
• Olsen R. W., Szamraj O., and Houser C. R. (1987) [3H]AMPA binding to glutamate receptor subpopulations in rat brain.Brain Res. 402, 243–254.
  Article PubMed CAS Google Scholar
• Olverman H. J., Jones A. W., Mewett K. N., and Watkins J. C. (1988) Structure/activity relations of_N_-methyl-d-aspartate receptor ligands as studied by their inhibition of [3H]d-2-amino-5-phosphonopentanoic acid binding in rat brain membranes.Neuroscience 26, 17–31.
  Article PubMed CAS Google Scholar
• Olverman H. J., Jones A. W., and Watkins J. C. (1984) L-glutamate has higher affinity than other amino acids for [3H]-d-AP5 binding sites in rat brain membranes.Nature 307, 460–462.
  Article PubMed CAS Google Scholar
• Perry T. L., Yong V. W., Bergeron C., Hansen S., and Jones K. (1987) Amino acids, glutathione, and glutathione transferase activity in the brains of patients with Alzheimer’s disease.Ann. Neurol. 21, 331–336.
  Article PubMed CAS Google Scholar
• Pettegrew J. W. (1989) Molecular insights into Alzheimer’s disease, in_Calcium, Membranes, Aging, and Alzheimer’s Disease_ (Khachaturian Z., Cotman C., and Pettegrew J. W., eds.), p. 5, New York Academy of Sciences, New York.
  Google Scholar
• Pettegrew J. W., Kopp S. J., Minshew N. J., Glonek T., Feliksik J. M., Tow T. P., and Cohen M. M. (1987a)31P Nuclear Magnetic Resonance studies of phosphoglyceride metabolism in developing and degenerating brain: Preliminary observations.J. Neuropathol. Exp. Neurol. 46, 419–430.
  Article PubMed CAS Google Scholar
• Pettegrew J. W., Minshew N. J., Cohen M. M., Kopp S. J., and Glonek T. (1984) P-31 NMR changes in Alzheimer’s and Huntington’s disease brain.Neurology 34, 281 (abstract).
  Google Scholar
• Pettegrew J. W., Moossy J., Withers G., McKeag D., and Panchalingam K. (1988a)31P Nuclear magnetic resonance study of the brain in Alzheimer’s disease.J. Neuropathol. Exp. Neurol. 47, 235–248.
  Article PubMed CAS Google Scholar
• Pettegrew J. W. and Panchalingam K. (1990) Solid state31P and27Al NMR studies of model membranes and mammalian brain: Possible implications for Alzheimer’s disease, in_NMR Principles and Applications to Biomedical Research_ (Pettegrew J. W., ed.), p. 310. Springer-Verlag, New York.
  Google Scholar
• Pettegrew J. W., Panchalingam K., Moossy J., Martinez J. A., Rao G., and Boller F. (1988b) Correlation of31P NMR and morphologic findings in Alzheimer’s disease.Arch. Neurol. 45, 1093–1096.
  PubMed CAS Google Scholar
• Pettegrew J. W., Panchalingam K., Withers G., McKeag D., and Strychor S. (1990) Changes in brain energy and phospholipid metabolism during development and aging in the Fischer 344 rat.J. Neuropathol. Exp. Neurol. 49, 237–249.
  Article PubMed CAS Google Scholar
• Pettegrew J. W., Withers G., Panchalingam K., and Post J. F. (1987b)31P nuclear magnetic resonance (NMR) spectroscopy of brain in aging and Alzheimer’s disease.J. Neural. Transm. 24, (Suppl.) 261–268.
  CAS Google Scholar
• Pin J. P., Bockaert J., and Recasesn M. (1984) The Ca2+/Cl− dependentl-[3H]glutamate binding: A new receptor or a particular transport process?FEBS Lett. 175, 31–36.
  Article PubMed CAS Google Scholar
• Procter A. W., Lowe S. L., Palmer A. M., Francis P. T., Esiri M. M., Stratmann G. C., Najlerahim A., Patel A. J., Hunt A., and Bowen D. M. (1988a) Topographical distribution of neurochemical changes in Alzheimer’s disease.J. Neurol. Sci. 84, 125–140.
  Article PubMed CAS Google Scholar
• Procter A. W., Palmer A. M., Francis P. T., Lowe S. L., Neary D., Murphy E., Doshi R., and Bowen D. M. (1988b) Evidence of glutamatergic denervation and possible abnormal metabolism in Alzheimer’s disease.J. Neurochem. 50, 790–802.
  Article PubMed CAS Google Scholar
• Procter A. W., Stirling J. M., Stratmann G. C., Cross A. J., and Bowen D. M. (1989a) Loss of glycine-dependent radioligand binding to the_N_-methyl-d-aspartate-phencyclidine receptor complex in patients with Alzheimer’s disease.Neurosci. Lett. 101, 62–66.
  Article PubMed CAS Google Scholar
• Procter A. W., Wong E. H., Stratmann G. C., Lowe S. L., and Bowen D. M. (1989b) Reduced glycine stimulation of [3H]MK-801 binding in Alzheimer’s disease.J. Neurochem. 53, 698–704.
  Article PubMed CAS Google Scholar
• Reynolds I. J. and Miller R. J. (1988) Multiple sites for the regulation of the_N_-methyl-d-aspartate receptor.Mol. Pharmacol. 33, 581–584.
  PubMed CAS Google Scholar
• Reynolds I. J., Murphy S. N., and Miller R. J. (1987) [3H]-labeled MK-801 binding to the excitatory amino acid receptor complex from rat brain is enhanced by glycine.Proc. Natl. Acad. Sci. USA 84, 7744–7748.
  Article PubMed CAS Google Scholar
• Sanfeliu C., Hunt A., and Patel A. J. (1990) Death of subcortical cholinergic neurons in certain neurodegenerative disorders may not be due to an overstimulation of N-methyl-d-aspartate receptors.Brain Res. 506, 319–322.
  Article PubMed CAS Google Scholar
• Sasaki H., Muramoto O., Kanazawa I., Arai H., Kosaka K., and Iizuka R. (1986) Regional distribution of amino acid transmitters in postmortem brains of presenile and senile dementia of Alzheimer type.Ann. Neurol 19, 263–269.
  Article PubMed CAS Google Scholar
• Schoepp D. D. and Johnson B. G. (1989) Comparison of excitatory amino acid-stimulated phosphoinositide hydrolysis and N-[3H]acetylaspartylglutamate binding in rat brain: Selective inhibition of phosphoinositide hydrolysis by 2-amino-3-phosphonopropionate.J. Neurochem. 53, 273–278.
  Article PubMed CAS Google Scholar
• Schoepp D. D., Johnson B. G., Smith E. C., and McQuaid L. A. (1990) Stereo-selectivity and mode of inhibition of phosphoinositide-coupled excitatory amino acid receptors by 2-amino-3-phosphonopropionic acid.Mol. Pharmacol. 38, 222–228.
  PubMed CAS Google Scholar
• Simpson M. D., Royston M. C., Deakin J. F., Cross A. J., Mann D. M., and Slater P. (1988) Regional changes in [3H]d-aspartate and [3H]TCP binding sites in Alzheimer’s disease brains.Brain Res. 462, 76–82.
  Article PubMed CAS Google Scholar
• Slaughter M. M. and Miller R. F. (1985) Characterization of an extended glutamate receptor of the on bipolar neuron in the vertebrate retina.J. Neurosci. 5, 224–233.
  PubMed CAS Google Scholar
• Steele J. E., Palmer A. M., Stratmann G. C., and Bowen D. M. (1989) The_N_-methyl-d-aspartate receptor complex in Alzheimer’s disease: Reduced regulation by glycine but not zinc.Brain Res. 500, 369–373.
  Article PubMed CAS Google Scholar
• Sundaralingam M. and Putkey E. F. (1970) Molecular structures of amino acids and peptides. II. A redetermination of the crystal structure ofl-_O_-serine phosphate. A very short phosphate-carboxyl hydrogen bond.Acta Cryst. B26, 790–800.
  Article CAS Google Scholar
• Vincent S. R. and McGeer E. G. (1980) A comparison of sodium-dependent glutamate binding with high-affinity glutamate uptake in rat striatum.Brain Res. 184, 99–108.
  Article PubMed CAS Google Scholar